I agree that this site is using cookies. You can find further informations here.
X
Abril-Fornaguera, Jordi
21  results:
Search for persons X
?
1

FRI-467 Efficacy of WNTinib, a novel selective therapeutic ..:

Balaseviciute, Ugne ; Abril-Fornaguera, Jordi ; Huguet-Pradell, Júlia...
Journal of Hepatology.  80 (2024)  - p. S417-S418 , 2024
Link: https://doi.org/10.1016/..
 
?
2

TOP-507-YI Single-cell RNA sequencing-derived gene signatur..:

Cappuyns, Sarah ; Piqué-Gili, Marta ; Esteban-Fabró, Roger...
Journal of Hepatology.  80 (2024)  - p. S411-S412 , 2024
Link: https://doi.org/10.1016/..
 
?
3

Predicting response to atezolizumab plus bevacizumab in adv..:

Cappuyns, Sarah ; Piqué-Gili, Marta ; Esteban-Fabró, Roger...
Journal of Hepatology.  78 (2023)  - p. S52-S53 , 2023
Link: https://doi.org/10.1016/..
 
?
4

WNTinib is a multi-kinase inhibitor with specificity agains..:

Rialdi, Alex ; Duffy, Mary ; Scopton, Alex P....
Nature Cancer.  4 (2023)  8 - p. 1157-1175 , 2023
Link: https://doi.org/10.1038/..
 
?
5

Liver Injury Increases the Incidence of HCC following AAV G..:

Dalwadi, Dhwanil A. ; Torrens, Laura ; Abril-Fornaguera, Jordi...
Molecular Therapy.  29 (2021)  2 - p. 680-690 , 2021
Link: https://doi.org/10.1016/..
 
?
6

Epigenetic footprint enables molecular risk stratification ..:

Carrillo-Reixach, Juan ; Torrens, Laura ; Simon-Coma, Marina...
Journal of Hepatology.  73 (2020)  2 - p. 328-341 , 2020
Link: https://doi.org/10.1016/..
 
?
7

Cabozantinib enhances the efficacy and immune modulatory ac..:

Esteban-Fabró, Roger ; Willoughby, Catherine E. ; Piqué-Gili, Marta...
Journal of Hepatology.  73 (2020)  - p. S40 , 2020
Link: https://doi.org/10.1016/..
 
?
8

Identification of IGF2 as Genomic Driver and Actionable The..:

Abril-Fornaguera, Jordi ; Torrens, Laura ; Andreu-Oller, Carmen...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10073300/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
9

Cabozantinib enhances anti-PD1 activity and elicits a neutr..:

Esteban-Fabró, Roger ; Willoughby, Catherine E ; Piqué-Gili, Marta...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9167725/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
10

Liver Injury Increases the Incidence of HCC following AAV G..:

Dalwadi, Dhwanil A ; Torrens, Laura ; Abril-Fornaguera, Jordi...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7854305/.  , 2021
Link: http://www.ncbi.nlm.nih...
 
?
11

Epigenetic footprint enables molecular risk stratification ..:

Carrillo-Reixach, Juan ; Torrens, L ; Simón-Coma, Marina...
Instituto de Salud Carlos III PI09-00751.  , 2020
Link: https://ddd.uab.cat/reco..
 
?
12

Epigenetic footprint enables molecular risk stratification ..:

Carrillo-Reixach, Juan ; Torrens, Laura ; Simon-Coma, Marina...
http://hdl.handle.net/10668/15313.  , 2020
Link: http://hdl.handle.net/10..
 
?
13

Immunomodulatory effects of lenvatinib plus anti-programmed..:

Torrens, Laura ; Montironi, Carla ; Puigvehí, Marc...
Hepatology. 2021;74(5):2652-69.  ,
Link: http://hdl.handle.net/10..
 
?
14

Immunomodulatory effects of lenvatinib plus anti-PD1 in mic..:

Torrens, Laura ; Montironi, Carla ; Puigvehí, Marc...
Versió postprint del document publicat a: https://doi.org/10.1002/hep.32023.  , 2021
Link: http://hdl.handle.net/24..
 
?
15

Epigenetic footprint enables molecular risk stratification ..:

Carrillo Reixach, Juan ; Torrens, Laura ; Simon Coma, Marina...
Reproducció del document publicat a: https://doi.org/10.1016/j.jhep.2020.03.025.  , 2020
Link: http://hdl.handle.net/24..
 
1-15